By: Jonathan S. Myers, MD; Douglas J. Rhee, MD
This course has expired. You can still review the content but course credit is no longer available.
Two new drugs in novel classes were approved recently for IOP reduction in eyes with ocular hypertension or open-angle glaucoma. View this webinar, hosted by two glaucoma experts, to learn more about these new treatments, plus therapeutics pending approval by the FDA. A case series is also included in this presentation.
This Activity is supported by an unrestricted educational grant from Aerie.
Upon completion of this activity, the participant should be able to:
Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve is an approved COPE Administrator. This course is COPE approved for 1.0 hours of CE Credit for Optometrists.
Course #63761-GL
COPE Activity ID #117840
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
EDITORIAL SUPPORT DISCLOSURES
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, or Aerie.